Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Urelumab> ?p ?o. }
Showing items 1 to 31 of
31
with 100 items per page.
- Urelumab abstract "Urelumab (ue rel' ue mab; also known as BMS-663513 and anti-4-1BB antibody) is a fully human IgG4 monoclonal antibody developed by Bristol-Myers Squibb for the treatment of cancer and solid tumors.Urelumab targets the CD137 receptor. It specifically binds to and activates CD137-expressing immune cells, stimulating an immune response, in particular a cytotoxic T cell response, against tumor cells.".
- Urelumab atcPrefix "none".
- Urelumab casNumber "934823-49-1".
- Urelumab wikiPageID "33024178".
- Urelumab wikiPageRevisionID "532988878".
- Urelumab atcPrefix "none".
- Urelumab c "6502".
- Urelumab casNumber "934823".
- Urelumab chemspiderid "NA".
- Urelumab h "9972".
- Urelumab hasPhotoCollection Urelumab.
- Urelumab mabType "mab".
- Urelumab molecularWeight "145.8".
- Urelumab n "1712".
- Urelumab o "2030".
- Urelumab s "44".
- Urelumab source "u".
- Urelumab target CD137.
- Urelumab type "mab".
- Urelumab verifiedfields "changed".
- Urelumab verifiedrevid "470620242".
- Urelumab subject Category:Bristol-Myers_Squibb.
- Urelumab type Drug.
- Urelumab type FunctionalSubstance.
- Urelumab comment "Urelumab (ue rel' ue mab; also known as BMS-663513 and anti-4-1BB antibody) is a fully human IgG4 monoclonal antibody developed by Bristol-Myers Squibb for the treatment of cancer and solid tumors.Urelumab targets the CD137 receptor. It specifically binds to and activates CD137-expressing immune cells, stimulating an immune response, in particular a cytotoxic T cell response, against tumor cells.".
- Urelumab label "Urelumab".
- Urelumab sameAs m.0h54zb2.
- Urelumab sameAs Q7900382.
- Urelumab sameAs Q7900382.
- Urelumab wasDerivedFrom Urelumab?oldid=532988878.
- Urelumab isPrimaryTopicOf Urelumab.